<?xml version="1.0" encoding="UTF-8"?>
<references>
<reference>
  <a1>Kim, H. U.</a1>
  <a2>Alten, R.</a2>
  <a2>Avedano, L.</a2>
  <a2>Dignass, A.</a2>
  <a2>Gomollón, Fernando</a2>
  <a2>Greveson, K.</a2>
  <a2>Halfvarson, J.</a2>
  <a2>Irving, P. M.</a2>
  <a2>Jahnsen, J.</a2>
  <a2>Lakatos, P. L.</a2>
  <a2>Lee, J. H.</a2>
  <a2>Makri, S.</a2>
  <a2>Parker, B.</a2>
  <a2>Peyrin-Biroulet, L.</a2>
  <a2>Schreiber, S.</a2>
  <a2>Simoens, S.</a2>
  <a2>Westhovens, R.</a2>
  <a2>Danese, S.</a2>
  <a2>Jeong, J. H.</a2>
  <t1>The Future of Biosimilars: Maximizing Benefits Across Immune-Mediated Inflammatory Diseases</t1>
  <t2>Drugs</t2>
  <sn/>
  <op/>
  <vo/>
  <ab/>
  <la>eng</la>
  <k1/>
  <pb/>
  <pp/>
  <yr>2020</yr>
  <ed/>
  <ul>http://zaguan.unizar.es/record/153636/files/texto_completo.pdf;
	http://zaguan.unizar.es/record/153636/files/texto_completo.jpg?subformat=icon;
	</ul>
  <no>Imported from Invenio.</no>
</reference>

</references>